Technical Analysis for POLX - Polarean Imaging Plc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 3.80 | -2.56% | -0.10 |
POLX closed down 2.56 percent on Thursday, April 25, 2024, on 15 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
180 Bearish Setup | Bearish Swing Setup | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Bullish Engulfing | Bullish | -2.56% | |
Hammer Candlestick | Bullish | -2.56% | |
Pocket Pivot | Bullish Swing Setup | -2.56% |
Alert | Time |
---|---|
Down 2% | about 20 hours ago |
Down 1% | about 20 hours ago |
Hammer Candlestick Entry | about 20 hours ago |
Rose Above Previous Day's High | about 20 hours ago |
Up 2% | about 20 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Polarean Imaging Plc is a medical drug-devising company. The Company with its subsidiaries operates in the medical imaging market and develops equipment to enable existing magnetic resonance imaging (MRI) systems. The Company focuses on improving the level of pulmonary functional imaging, and specializing the use of polarised Xenon gas (129Xe) as an imaging agent to visualize ventilation, and gas exchange. The Group also develops and manufactures high performance MRI radiofrequency (RF) coils which are a required for imaging 129Xe in the MRI system. The United States food and drug administration (FDA) has accepted the group’s III clinical trial and design.
Sector: Healthcare
Industry: Medical Devices
Keywords: Oil Gas Food Medicine Clinic Imaging Radio Ventilation Academic Disciplines Mr Oils Clinical Trial Medical Imaging Applied Sciences Magnetic Resonance Imaging Medical Physics Mri Cryogenics Food And Drug Administration Medical Imaging Market Magnetic Resonance
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Oil Gas Food Medicine Clinic Imaging Radio Ventilation Academic Disciplines Mr Oils Clinical Trial Medical Imaging Applied Sciences Magnetic Resonance Imaging Medical Physics Mri Cryogenics Food And Drug Administration Medical Imaging Market Magnetic Resonance
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 33.0 |
52 Week Low | 3.675 |
Average Volume | 1,036,179 |
200-Day Moving Average | 8.77 |
50-Day Moving Average | 4.69 |
20-Day Moving Average | 3.97 |
10-Day Moving Average | 3.90 |
Average True Range | 0.25 |
RSI (14) | 32.89 |
ADX | 29.76 |
+DI | 13.64 |
-DI | 20.44 |
Chandelier Exit (Long, 3 ATRs) | 3.85 |
Chandelier Exit (Short, 3 ATRs) | 4.47 |
Upper Bollinger Bands | 4.30 |
Lower Bollinger Band | 3.63 |
Percent B (%b) | 0.25 |
BandWidth | 17.03 |
MACD Line | -0.24 |
MACD Signal Line | -0.28 |
MACD Histogram | 0.0476 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.87 | ||||
Resistance 3 (R3) | 3.88 | 3.86 | 3.86 | ||
Resistance 2 (R2) | 3.86 | 3.85 | 3.86 | 3.86 | |
Resistance 1 (R1) | 3.83 | 3.83 | 3.82 | 3.82 | 3.85 |
Pivot Point | 3.82 | 3.82 | 3.81 | 3.81 | 3.82 |
Support 1 (S1) | 3.78 | 3.80 | 3.78 | 3.78 | 3.75 |
Support 2 (S2) | 3.77 | 3.79 | 3.76 | 3.74 | |
Support 3 (S3) | 3.74 | 3.77 | 3.74 | ||
Support 4 (S4) | 3.73 |